← Back to Compounds
injectableanabolic

Drostanolone Propionate

MasteronMast PDrostanolone
62
Anabolic Ratio
25
Androgenic Ratio
2.5d
Half-Life

DHT-derivative with anti-estrogenic properties (weak aromatase inhibitor). Produces muscle density and hardness with no water retention. Best at low body fat. Often used as a 'dry' compound finishing cycle.

Mechanism of Action

Does not aromatize. Acts as a mild competitive aromatase inhibitor, lowering estrogen levels. Binds SHBG, freeing more free testosterone. DHT-derived, so minimal 5α-reduction, but androgenic at scalp.

Drostanolone Propionate molecule
Molecular structure

Typical Dosing

200 mg
low / week
400 mg
moderate / week
700 mg
high / week

⚠ Warning Flags

  • •Hair loss acceleration in DHT-sensitive individuals

Effect Profile

Muscle Protein Synthesis
4Low
Nitrogen Retention
4Low
Strength Gains
5Moderate
Red Blood Cell Production
2Minimal
Fat Loss
6Moderate
Glycogen Storage
3Low
Recovery Speed
4Low
Collagen Synthesis
3Low

Side Effect Profile

Hormonal Suppression
4Low
Estrogenic Effects
1Minimal
Androgenic Effects
5Moderate
Cardiovascular Strain
3Low
Liver Stress
1Minimal
Insulin Resistance
1Minimal
Mood Changes
3Low
Prostate Risk
3Low

Research Studies

Pharmacology of anabolic steroids

Kicman AT. · 2008

PubMed

Review documents drostanolone's unique anti-estrogenic mechanism and favorable side-effect profile, explaining its use as a finishing compound.